Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the Company’s solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer.
GeneXpert technology is a revolutionary molecular diagnostics system which has developed a number of in vitro diagnostics (IVD) Xpert tests in areas including HAIs, CIDs and Women’s Health. Modular in design, the GeneXpert System has various configurations to meet the broad range of testing demands of any clinical environment and uses the same patented cartridge technology for every Xpert test. Our GeneXpert family of systems have set a new standard in workflow flexibility, 24/7 testing accuracy, and user-friendly design; delivered in an astonishingly beautiful and compact package.